EUVIMEDEUVIMED entdecken
Crossref

In Vitro Assessment of the Extended 21-Day Microbial Barrier Provided by the Exofin Fusion Surgical Incision Closure System

Chaitanya Dev Pannu iD

Surgical Infections · 2025

DOI: 10.1089/sur.2024.207 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Surgical Infections, 2025. Verfasst von Chaitanya Dev Pannu. Beteiligte Einrichtung: Royal National Orthopaedic Hospital, London, United Kingdom. Hauptthemen laut MEDLINE: Tissue Adhesives, Bacteria, Cyanoacrylates, Wound Closure Techniques. Die Arbeit nennt 24 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Tissue adhesives are increasingly being used as alternatives to traditional sutures and staples in surgical incision closure applications. Exofin Fusion, a novel cyanoacrylate-based adhesive with a mesh, has been developed to enhance surgical incision closure. This study investigates the microbial barrier effectiveness of Exofin Fusion.

Methods

An in vitro assessment of 35 plates, including challenge organisms, negative controls, and positive controls, was conducted by an independent research organization, North American Science Associates, Inc (NAMSA), USA. Exofin Fusion was applied to the plates aseptically. Each plate was then inoculated with specific challenge organisms. Observations for visible growth or color changes in the media were made over a 21-day period.

Results

The results demonstrated no growth or color changes on test plates for common pathogens such as Staphylococcus aureus , Staphylococcus epidermidis , Methicillin-resistant Staphylococcus aureus , Pseudomonas aeruginosa , Escherichia coli , and Aspergillus brasiliensis throughout the 21-day period. Candida albicans showed no growth or color changes up to day 20; however, two out of five replicates exhibited growth on day 21.

Conclusions

The study confirms the microbial barrier properties of Exofin Fusion, as it effectively prevents the penetration of challenge organisms for the entire test period. Despite the growth of C. albicans in two replicates on day 21, the adhesive demonstrates remarkable efficacy in protecting against microbial infiltration. These findings suggest the potential clinical utility of Exofin Fusion in surgical incision closure applications, highlighting its significance in healthcare settings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tissue AdhesivesBacteriaCyanoacrylatesWound Closure TechniquesSurgical Wound InfectionHumans

Stichwörter der Autor:innen

2 octyl cyanoacrylateexofin fusionmicrobial barriersurgical site infectiontopical skin adhesive

Substanzen

Tissue AdhesivesCyanoacrylates

Autor:innen und Institutionen

  • Royal National Orthopaedic Hospital, London, United Kingdom.

ORCID-Profile: Chaitanya Dev Pannu

Zitieren

APA

Pannu, C. D. (2025). In Vitro Assessment of the Extended 21-Day Microbial Barrier Provided by the Exofin Fusion Surgical Incision Closure System. Surgical Infections. https://doi.org/10.1089/sur.2024.207

Vancouver

Pannu CD. In Vitro Assessment of the Extended 21-Day Microbial Barrier Provided by the Exofin Fusion Surgical Incision Closure System. Surgical Infections. 2025. doi:10.1089/sur.2024.207

BibTeX
@article{Pannu2025,
  author = {Pannu, Chaitanya Dev},
  title = {In Vitro Assessment of the Extended 21-Day Microbial Barrier Provided by the Exofin Fusion Surgical Incision Closure System},
  journal = {Surgical Infections},
  year = {2025},
  doi = {10.1089/sur.2024.207}
}
Kostenlos starten →